Skip to main content
Livermore
Livermore
ZHEN

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

GSK holding history

GSK plc in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
19,945
Value
$1.05M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,945$1.05M<0.1%+1,328+7.1%AddedHolders
Q1 202618,617$1.03M<0.1%+640+3.6%AddedHolders
Q4 202517,977$881.6K<0.1%−959−5.1%ReducedHolders
Q3 202518,936$817.3K<0.1%−2,385−11.2%ReducedHolders
Q2 202521,321$818.7K<0.1%+2,252+11.8%AddedHolders
Q1 202519,069$738.7K<0.1%+4,018+26.7%AddedHolders
Q4 202415,051$509.0K<0.1%−3,567−19.2%ReducedHolders
Q3 202418,618$761.1K<0.1%+245+1.3%AddedHolders
Q2 202418,373$707.4K<0.1%−152−0.8%ReducedHolders
Q1 202418,525$794.2K<0.1%+1,240+7.2%AddedHolders
Q4 202317,285$640.6K<0.1%+450+2.7%AddedHolders
Q3 202316,835$610.3K<0.1%+542+3.3%AddedHolders
Q2 202316,293$580.7K<0.1%+661+4.2%AddedHolders
Q1 202315,632$556.2K<0.1%+2,930+23.1%AddedHolders
Q4 202212,702$446.3K<0.1%+1,423+12.6%AddedHolders
Q3 202211,279$332.0K<0.1%−7,728−40.7%ReducedHolders
Q2 202219,007$827.0K<0.1%−281−1.5%ReducedHolders
Q1 202219,288$840.0K<0.1%−792−3.9%ReducedHolders
Q4 202120,080$886.0K<0.1%−2,651−11.7%ReducedHolders
Q3 202122,731$869.0K<0.1%+4,073+21.8%AddedHolders
Q2 202118,658$743.0K<0.1%+2,098+12.7%AddedHolders
Q1 202116,560$591.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.